This information was published on 2026-01-29T05:07:50 for IP Right Filed Published.
| Field | Value |
| (210) | 2622575 (IR 1899455) |
| (220) |
19 Dec 2025
|
| (300) |
US, 20 Jun 2025, 99245347
|
| (511) (510) |
Class 5
Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations. |
| (540) | RETRIG |
| (550) | Word |
| (730) |
SFJ Pharma X, Inc.
|
Find out more about publications on the About page.